|
Dr. Gadicke has served as a director since February 2003. Dr. Gadicke is the founder and a General Partner of the MPM Group. He led MPM’s effort to build its Advisory and Investment Banking business from 1992 to 1996 and started its Asset Management business in 1996. Prior to founding MPM, Dr. Gadicke was employed by The Boston Consulting Group. He has held research positions in biochemistry and molecular biology at the Whitehead Institute at MIT, Harvard University and the German Cancer Research Center. Dr.Gadicke is currently a director of Pharmasset, Inc. (NASDAQ:VRUS). He previously served as a director of BioMarin (NASDAQ:BMRN), Biovitrum (Stockholm:BVT), Idenix (NASDAQ:IDIX), MediGene (Frankfurt:MDG), Omrix Biopharmaceuticals (NASDAQ:OMRI), PharmAthene (AMEX:PIP) and Viacell (NASDAQ:VIAC). He is a member of the Advisory Council for Harvard Medical School. Dr. Gadicke holds an M.D. from J.W. Goethe University in Frankfurt. | 